Latest News & Updates
Breaking News
1 hour ago
Vaibhavi M.
Other trending news you may like to read
Ocugen Reports Positive Phase 2 Interim Data; OCU410 Gene Therapy Shows Reduced Lesion Growth And Favourable Safety In dAMD
Ocugen shares positive interim Phase 2 results for OCU410, demonstrating meaningful reduction in lesion growth in geographic atrophy patients.
Vaibhavi M.
GT Biopharma Submits IND To FDA For GTB-5550 TriKE, A B7-H3-Targeted NK Cell Engager For Treating B7-H3–Expressing Solid Tumor Cancers
GT Biopharma submits an FDA IND for GTB-5550, a B7-H3–targeted TriKE NK cell engager planned for Phase 1 solid tumor studies.
Simantini Singh Deo
Hikma Achieves B Scores For Climate Change And Water Security In Carbon Disclosure Project 2025; Strengthens Environmental Performance
Hikma earns B scores in CDP 2025 for Climate Change and Water Security, reflecting improved environmental performance.
Vaibhavi M.
Oncolytics Biotech® Strengthens Leadership Team With John McAdory As EVP And Yujun Wu As Head Of Biostatistics
Oncolytics names John McAdory EVP Strategy and Yujun Wu VP Biostatistics to support late-stage oncology trials.
Simantini Singh Deo
